Last updated on August 27, 2025
Check out the Latest Amanta Healthcare IPO GMP Today, aka Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. The Amanta Healthcare IPO date is fixed. The issue will be open for subscription from September 1, 2025, and will close on September 3, 2025.
Amanta Healthcare Limited is coming out with its Initial Public Offering (IPO) to raise funds through a 100% book-built issue of up to 1 crore equity shares of face value ₹10 each.
The retail quota for this IPO is 35%, the QIB allocation is 50% (with Anchor Investors accounting for up to 60% of the QIB portion), and the HNI allocation is 15%.
What is Amanta Healthcare IPO GMP Price Today?
The Amanta Healthcare IPO GMP Price, also known as Grey Market Premium, is ₹ as of Today.
What is Amanta Healthcare IPO Kostak Rates Today?
The Amanta Healthcare IPO Kostak Rate is ₹-.
What is Amanta Healthcare IPO Subject to Sauda Price Today?
The Amanta Healthcare IPO subject to sauda rates is ₹1900.
What is Amanta Healthcare IPO Expected Returns?
The Amanta Healthcare IPO expected return is 2448 Rs.
Amanta Healthcare IPO GMP Price Today
Amanta Healthcare Company Introduction
Amanta Healthcare Limited is coming out with its Initial Public Offering (IPO) to raise funds through a 100% book built issue of up to 1 crore equity shares of face value ₹10 each. The Ahmedabad-based pharmaceutical company, originally incorporated in 1994 as Marck Parenterals (India) Limited, later rebranded itself as Amanta Healthcare Limited in 2014. The IPO consists entirely of a fresh issue, with no offer-for-sale component, and the funds will be utilised for business expansion and corporate purposes.
The bidding window will open for anchor investors on August 29, 2025, followed by the main issue period from September 1 to September 3, 2025. The equity shares will be listed on both BSE and NSE, with NSE designated as the lead exchange. The company’s promoters include Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendrakumar Patel, and Milcent Appliances Pvt. Ltd.
What is Grey Market Premium (GMP)?
The grey market premium (GMP) in the context of an Initial Public Offering (IPO) refers to the difference between the unofficial market price of the shares and the IPO price. The grey market is an informal over-the-counter market where trading of shares takes place before they are officially listed on a stock exchange. This trading occurs among investors and brokers, and it is not regulated by stock exchanges or securities regulators. A positive GMP indicates demand at a higher price than the IPO. It serves as an informal indicator of market sentiment and demand but lacks regulatory oversight. Investors should approach GMP with caution, considering it may not accurately reflect actual market conditions post-listing.
What is Kostak Rate?
The Kostak rate is the amount that one buyer pays to the seller of an IPO application before the IPO listing. As the grey market reacts, the Kostak rates also react the same way. One can buy and sell their full IPO application on Kostak rates outside the market and fix their profit. The buyer must pay the Kostak rates for application, whether the investor gets the IPO allotment or not.
What is Subject to Sauda in IPO Grey Market?
“Subject to Sauda” on an IPO application is the agreed-upon amount when investors receive allotment for their IPO shares. Buying or selling the IPO application subject to sauda implies that the specified amount can be obtained upon allotment; otherwise, the sauda arrangement will be canceled. Profit cannot be fixed, as it depends on the share allotment in IPO application.
Dislcaimer:
- IPO Grey Market Premium mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change any time before listing. Subscribe only considering the fundamentals of the companies.